Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis (original) (raw)

References

  1. Matrisian LM: The matrix-degrading metalloproteinases. BioEssays 14: 455–463, 1992
    Google Scholar
  2. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix Metalloproteinases: A Review. Critical Reviews in Oral Biology and Medicine 4: 197–250, 1993
    Google Scholar
  3. Alexander CM, Werb Z: Proteinases and extracellular matrix remodeling. Curr Op Cell Biol 1: 974–982, 1989
    Google Scholar
  4. Gross J, Lapiere CM: Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 54: 1197–1204, 1962
    Google Scholar
  5. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61–64, 1994
    Google Scholar
  6. Springman E, Angleton E, Birkedal-Hansen H, Van Wart H: Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys 73 active-site zinc complex in latency and a ‘cysteine switch’ mechanism for activation. Proc Natl Acad Sci USA 87: 364–368, 1990
    Google Scholar
  7. Matrisian LM, Hogan BLM: Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 24: 219–259, 1990
    Google Scholar
  8. Opdenakker G, Van Damme J: Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 4: 251–258, 1995
    Google Scholar
  9. Mauviel A: Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53: 288–295, 1993
    Google Scholar
  10. Matrisian L, Leroy P, Ruhlmann C, Gesnel M, Breathnach R: Isolation of the oncogene and epidermal growth factorinduced transin gene: Complex control in rat fibroblasts. Mol Cell Biol 6: 1678–1686, 1986
    Google Scholar
  11. Overall CM, Wrana JL, Sodek J: Transcriptional and posttranscriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-betal in human fibroblasts: Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 266: 14064–14071, 1991
    Google Scholar
  12. Delany AM, Brinckerhoff CE: Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Biochem 50: 400–410, 1992
    Google Scholar
  13. Powell WC, Matrisian LM: Complex roles of matrix metalloproteinases in tumor progression. In: Gunthert U, Schlag PM, Birchmeier W (eds) 1995, in press
  14. Hirose T, Patterson C, Pourmotabbed T, Mainardi CL, Hasty KA: Structure-function relationship of human neutrophil collagenase: Identification of regions responsible for substrate specificity and general proteinase activity. Proc Natl Acad Sci USA 90: 2569–2573, 1993
    Google Scholar
  15. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67–68, 1980
    Google Scholar
  16. Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA: Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with_c_-Ha-ras but not c-Ha-ras plus Ad2-Ela. Cancer Res 47: 1523–1528, 1987
    Google Scholar
  17. Bernhard EJ, Muschel RJ, Hughes EN: Mr92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50 (13): 3872–3877, 1990
    Google Scholar
  18. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO: Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Research 52: 4942–4947, 1992
    Google Scholar
  19. MacDougall JR, Bani MR, Lin Y, Rak J, Kerbel RS: The 92 kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55: 4174–4181, 1995
    Google Scholar
  20. Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoto M, Nakamura H, Imai K, Yachi A: Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun 201: 657–664, 1994
    Google Scholar
  21. McDonnell S, Navre M, Coffey RJ, Matrisian LM: Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinogenesis 4: 527–533, 1991
    Google Scholar
  22. Newell KJ, Witty JP, Rodgers WH, Matrisian LM: Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10: 199–206, 1994
    Google Scholar
  23. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG: Increased expression of the_M_ r 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51: 439–444, 1991
    Google Scholar
  24. Azzam HS, Arand GA, Lippman ME, Thompson EW: MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. J Natl Cancer Inst 85: 1758–1764, 1993
    Google Scholar
  25. De Clerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708, 1992
    Google Scholar
  26. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P: Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. JNCI 84: 1017–1022, 1992
    Google Scholar
  27. Khokha R, Zimmer MJ, Wilson SM, Chambers AF: Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 10: 365–370, 1992
    Google Scholar
  28. Schultz R, Silberman S, Persky B, Bajkowski A, Carmichael D: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539–5545, 1988
    Google Scholar
  29. Alvarez OA, Carmichael DF, DeClerck YA: Inhibition of collagenolytic activity and metastatic of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82: 589–595, 1990
    Google Scholar
  30. Chirivi RG, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, Giavazzi R: Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 58: 460–464, 1995
    Google Scholar
  31. Khokha R, Waterhouse P, Yagel S, Lala P, Overall C, Norton G, Denhardt D: Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 244: 947–950, 1989
    Google Scholar
  32. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC: Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54: 4791–4797, 1994
    Google Scholar
  33. Montgomery AMP, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA: Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467–5473, 1994
    Google Scholar
  34. Witty JP, McDonnell S, Newell K, Cannon P, Navre M, Tressler R, Matrisian LM: Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity_in vivo_. Cancer Res 54: 4805–4812, 1994
    Google Scholar
  35. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RJ: Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54: 4726–4728, 1995
    Google Scholar
  36. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR: A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53: 2087–2091, 1993
    Google Scholar
  37. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699–704, 1990
    Google Scholar
  38. Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio M-C, Eber M, Methlin G, Chambon P, Basset P: Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 53: 165–169, 1993
    Google Scholar
  39. Wolf C, Chenard M-P, De Grossouvre PD, Bellocq J-P, Chambon P, Basset P: Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol 99: 870–872, 1992
    Google Scholar
  40. Pyke C, Ralfki!ae!r E, Tryggvason K, Dano K: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359–365, 1993
    Google Scholar
  41. Okada A, Bellocq J, Chenard M, Rio M, Chambon P, Basset P: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas. Proc Natl Acad Sci USA 92: 2730–2734. PNAS 92: 2730–2734, 1995
    Google Scholar
  42. Majmudar G, Nelson BR, Jensen TC, Johnson TM: Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome. Mol Carcinog 11: 29–33, 1994
    Google Scholar
  43. Pyke C, Ralfki!ae!r E, Huhtala P, Hurskainen T, Tryggvason K: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by_in situ_ hybridization. Cancer Res 52: 1336–1341, 1992
    Google Scholar
  44. Canete-Soler R, Litzky L, Lubensky I, Muschel RJ: Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using_in situ_ hybridization. Am J Pathol 144: 518–527, 1994
    Google Scholar
  45. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR: Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncology Research 5: 19–28, 1993
    Google Scholar
  46. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq J-P, Chambon P, Basset P: Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90: 1843–1847, 1993
    Google Scholar
  47. Pajouh M, Nagle R, Breathnach R, Finch J, Brawer M, Bowden G: Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 117: 144–150, 1991
    Google Scholar
  48. Wilson CL, Heppner KJ, Rudolph LA, Matrisian LM: The metalloproteinase matrilysin is preferentially expressed in epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell 6: 851–869, 1995
    Google Scholar
  49. Saarialho-Kere UK, Crouch EC, Parks WC: The matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatology (in press): 1995
  50. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, Bayliss MT, Iwata K, Nagase H: Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66: 680–690, 1992
    Google Scholar
  51. Goldberg G, Wilhelm S, Kronberger A, Bauer E, Grant G, Eisen A: Human fibroblast collagenase; complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261: 6600–6605, 1986
    Google Scholar
  52. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG: Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94: 946–953, 1994
    Google Scholar
  53. Klein-Szanto AJ, Larcher F, Bonfil RD, Conti CJ: Multistage chemical carcinogenesis protocols produce spindle cell carcinomas of the mouse skin. Carcinogenesis 10: 2169–2172, 1989
    Google Scholar
  54. Stoler AB, Stenback F, Balmain A: The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J Cell Biol 122: 1103–1117, 1993
    Google Scholar
  55. Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A, Matrisian LM: A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carinog 10: 207–215, 1994
    Google Scholar
  56. Killary AM, Fournier REK: A genetic analysis of extinction: trans-dominant loci regulate expression of liver-specific traits in hepatoma hybrid cells. Cell 38: 523–534, 1984
    Google Scholar
  57. Boshart M, Nitsch D, Schutz G: Extinction of gene expression in somatic cell hybrids - a reflection of important regulatory mechanisms? TIG 9: 240–245, 1995
    Google Scholar
  58. McDonnell SE, Kerr LD, Matrisian LM: Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 10: 4284–4293, 1990
    Google Scholar
  59. Kataoka H, DeCastro R, Zucker S, Biswas C: Tumor cellderived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 53: 3154–3158, 1993
    Google Scholar
  60. Himelstein BP, Canete-Soler R, Bernhard EJ, Muschel RJ: Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci 107: 477–486, 1994
    Google Scholar
  61. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y: Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. British Journal of Cancer 71: 1039–1045, 1995
    Google Scholar
  62. Borchers AH, Powell MB, Fusenig NE, Bowden GT: Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res 213: 143–147, 1994
    Google Scholar
  63. Clark W: Tumor progression and the nature of cancer. British Journal of Cancer 64: 631–644, 1991
    Google Scholar
  64. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109: 877–889, 1989
    Google Scholar
  65. Unemori EN, Werb Z: Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in or on collagen gels. J Cell Biol 102: 1021–1031, 1986
    Google Scholar
  66. Aggeler J, Frisch SM, Werb Z: Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts. J Cell Biol 98: 1662–1671, 1984
    Google Scholar
  67. MacDougall JR, Kerbel RS: Constitutive production of 92 kDa gelatinase B can be suppressed by alterations in cell shape. Exp Cell Res 218: 508–515, 1995
    Google Scholar
  68. Edvardsen K, Chen W, Rucklidge G, Walsh FS, Öbrink B, Bock E: Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc Natl Acad Sci USA 90: 11463–11467, 1993
    Google Scholar
  69. Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT: Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 53: 417–422, 1993
    Google Scholar
  70. Bernhard EJ, Gruber SB, Muschel RJ: Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 91: 4293–4297, 1994
    Google Scholar
  71. Docherty A, Lyons A, Smith B, Wright E, Stephens P, Harris T, Murphy G, Reynolds J: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 315: 761–768, 1985
    Google Scholar
  72. Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ, Hayakawa T: Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Exp Hematol 21: 169–176, 1993
    Google Scholar
  73. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A: Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 107: 2373–2379, 1994
    Google Scholar
  74. Emonard HP, Remacle AG, Noël AC, Grimaud J-A, Stetler-Stevenson WG, Foidart J-M: Tumor cell surface-associated binding site for the_M_ r 72,000 type IV collagenase. Cancer Res 52: 5845–5848, 1992
    Google Scholar
  75. Yu M, Sato H, Seiki M, Thompson EW: Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55: 3272–3277, 1995
    Google Scholar
  76. Okada A, Bellocq J, Rouyer N, Chenard M, Rio M, Chambon P, Basset P: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proceedings of the National Academy of Sciences of the United States of America: 2730–2734, 1995
  77. Witty JP, Lempka T, Coffey RJ Jr, Matrisian LM: Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 55: 1401–1406, 1995
    Google Scholar
  78. Johnson MD, Kim H-RC, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160: 194–202, 1994
    Google Scholar
  79. Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM, Stetler-Stevenson WG: Angiogenic potential_in vivo_ by Kaposi's sarcoma cell-free supernatants and HIV-1_tat_ product: Inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 8: 1237–1244, 1994
    Google Scholar
  80. Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, Brown PD, Giavazzi R: Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 87: 293–298, 1995
    Google Scholar
  81. Galardy RE, Grobelny D, Foellmer HG, Fernandez LA: Inhibition of angiogenesis by the matrix metalloprotease inhibitor_N_-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res 54: 4715–4718, 1994
    Google Scholar
  82. Moses MA, Langer R: A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 47: 230–235, 1991
    Google Scholar
  83. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA: Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93: 2357–2364, 1994
    Google Scholar
  84. Benelli R, Adatia R, Ensoli B, Stetler-Stevenson WG, Santi L, Albini A: Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncology Research 6: 251–257, 1994
    Google Scholar

Download references